Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC-DEF 14A
Name
Amount & Nature of
Beneficial Ownership
Percent of Class
Gloria H. Felcyn, CPA
1,439,700 (1)
*
Helmut Falk, Jr.
3,428,231 (2)
*
Carlton M. Johnson, Jr.
1,675,000 (3)
*
David H. Pohl
2,657,846 (4)
*
Thomas J. Sweeney
275,000 (5)
*
James L. Turley
1,075,000 (6)
*
Harry (Nick) L. Tredennick III
100,000 (7)
*
Lincoln Ventures, LLC
29,624,189 (8)
7.61%
Swartz Private Equity, LLC
5,759,940 (8)
1.48%
All directors & officers as a group (7 persons)
10,650,777 (9)
2.74%

Share
New Message
Please login to post a reply